
Panadiplon
CAS No. 124423-84-3
Panadiplon( —— )
Catalog No. M34371 CAS No. 124423-84-3
Panadiplon (FG 10571) is a selective gamma-aminobutyric acid receptor agonist and partial agonist of 5GABAA, a benzodiazepine receptor, used in the treatment of anxiety disorders.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 217 | Get Quote |
![]() ![]() |
5MG | 342 | Get Quote |
![]() ![]() |
10MG | 504 | Get Quote |
![]() ![]() |
25MG | 790 | Get Quote |
![]() ![]() |
50MG | 1086 | Get Quote |
![]() ![]() |
100MG | 1431 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePanadiplon
-
NoteResearch use only, not for human use.
-
Brief DescriptionPanadiplon (FG 10571) is a selective gamma-aminobutyric acid receptor agonist and partial agonist of 5GABAA, a benzodiazepine receptor, used in the treatment of anxiety disorders.
-
DescriptionPanadiplon (FG 10571; PNU 78875), a benzodiazepine receptor, is a 5GABAA partial agonist. Panadiplon exhibits selectivity for 5GABAA receptors versus 1GABAA receptors.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorGABA Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number124423-84-3
-
Formula Weight335.36
-
Molecular FormulaC18H17N5O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C=2N(C=3C(N1C(C)C)=CC=CC3)C=NC2C=4N=C(ON4)C5CC5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Platt DM, et al. Contribution of alpha 1GABAA and alpha 5GABAA receptor subtypes to the discriminative stimulus effects of ethanol in squirrel monkeys. J Pharmacol Exp Ther. 2005 May;313(2):658-67.?
molnova catalog



related products
-
Quercetin 3,7-digluc...
Quercetin 3,7-diglucoside exhibits antioxidant activity.
-
Polygalacin D2
Polygalacin D2 may have antimicrobial activity.
-
N3-C4-NHS ester
N3-C4-NHS ester is a non cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).